Moberg Pharma Receives Favorable Outcome From NAD - Main Competitor to Discontinue Current Marketing
STOCKHOLM, Jan. 15, 2018 /PRNewswire/ --Moberg Pharma AB (OMX: MOB) have received a positive outcome from the NAD (National Advertising Division) regarding a challenge filed on Fungi-Nail, the largest ...
A proposed consumer class suit against the makers of a nail fungus treatment will stay in federal court, as a federal trial court in California Jan. 4 said the putative class members’ claims exceed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results